PL354584A1 - Nowy preparat mirtazapiny - Google Patents

Nowy preparat mirtazapiny

Info

Publication number
PL354584A1
PL354584A1 PL00354584A PL35458400A PL354584A1 PL 354584 A1 PL354584 A1 PL 354584A1 PL 00354584 A PL00354584 A PL 00354584A PL 35458400 A PL35458400 A PL 35458400A PL 354584 A1 PL354584 A1 PL 354584A1
Authority
PL
Poland
Prior art keywords
distintegrating
mirtazapine
orally
composition
orally distintegrating
Prior art date
Application number
PL00354584A
Other languages
English (en)
Other versions
PL200858B1 (pl
Inventor
Nijs Henrik De
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240737&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL354584(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL354584A1 publication Critical patent/PL354584A1/pl
Publication of PL200858B1 publication Critical patent/PL200858B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL354584A 1999-10-13 2000-10-09 Jednostka dawkowania do podawania doustnie zawierająca mirtazapinę PL200858B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203338 1999-10-13
PCT/EP2000/009863 WO2001026621A2 (en) 1999-10-13 2000-10-09 Orally distintegrating composition comprising mirtazapine

Publications (2)

Publication Number Publication Date
PL354584A1 true PL354584A1 (pl) 2004-01-26
PL200858B1 PL200858B1 (pl) 2009-02-27

Family

ID=8240737

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354584A PL200858B1 (pl) 1999-10-13 2000-10-09 Jednostka dawkowania do podawania doustnie zawierająca mirtazapinę

Country Status (28)

Country Link
EP (1) EP1223914B1 (pl)
JP (1) JP5561885B2 (pl)
KR (1) KR100708560B1 (pl)
CN (1) CN1173701C (pl)
AR (1) AR026010A1 (pl)
AT (1) ATE274899T1 (pl)
AU (1) AU780379B2 (pl)
BR (1) BR0014593A (pl)
CA (1) CA2386547C (pl)
CO (1) CO5251412A1 (pl)
CZ (1) CZ20021315A3 (pl)
DE (2) DE1223914T1 (pl)
ES (1) ES2194618T3 (pl)
HK (1) HK1046641B (pl)
HU (1) HUP0203148A3 (pl)
IL (2) IL148777A0 (pl)
MX (1) MXPA02003519A (pl)
NO (1) NO20021730L (pl)
NZ (1) NZ518165A (pl)
PE (1) PE20010699A1 (pl)
PL (1) PL200858B1 (pl)
PT (1) PT1223914E (pl)
RU (1) RU2261098C2 (pl)
SK (1) SK6452002A3 (pl)
TR (1) TR200200978T2 (pl)
TW (1) TWI256309B (pl)
WO (1) WO2001026621A2 (pl)
ZA (1) ZA200202293B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346832C (zh) * 2002-02-07 2007-11-07 法玛西雅公司 经粘膜递送的药物剂型
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
AU2007221135A1 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN101129341B (zh) * 2006-08-22 2011-06-01 上海医药工业研究院 口内崩解组合物及其制备方法
EP2377522B1 (en) 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
CN102993208B (zh) * 2011-11-22 2017-01-18 北京哈三联科技股份有限公司 去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用
PE20142320A1 (es) * 2012-03-02 2015-01-16 Rhodes Pharmaceuticals Lp Formulaciones de liberacion inmediata resistentes a la manipulacion
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
RS62055B1 (sr) 2015-02-27 2021-07-30 Dechra Ltd Stimulacija apetita, upravljanje gubitkom težine i lečenje anoreksije kod pasa i mačaka
JP6601844B2 (ja) * 2016-12-05 2019-11-06 共和薬品工業株式会社 光安定性に優れたミルタザピン含有医薬製剤
CN111714463B (zh) * 2020-08-14 2022-06-17 华农（肇庆）生物产业技术研究院有限公司 米氮平口服剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DK0494972T3 (da) * 1989-10-02 1997-05-12 Cima Labs Inc Brusedosisform samt fremgangsmåde til administration heraf
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
JP3168695B2 (ja) * 1991-06-14 2001-05-21 三菱化学株式会社 ショ糖脂肪酸エステルの置換度の低下方法
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JPH05163137A (ja) * 1991-12-12 1993-06-29 Shin Etsu Chem Co Ltd 有核顆粒
DE69307908T2 (de) * 1992-10-07 1997-07-10 Akzo Nobel Nv Verfahren zur trennung von enantiomeren aus einer racemischen mischung
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
JPH0737473A (ja) * 1993-07-27 1995-02-07 Murata Mfg Co Ltd 圧力スイッチ
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
JP3870470B2 (ja) * 1997-02-07 2007-01-17 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Also Published As

Publication number Publication date
TWI256309B (en) 2006-06-11
NO20021730L (no) 2002-05-30
HUP0203148A3 (en) 2004-06-28
DE1223914T1 (de) 2003-09-18
CA2386547C (en) 2010-06-08
KR20020038946A (ko) 2002-05-24
MXPA02003519A (es) 2002-08-20
PT1223914E (pt) 2004-11-30
EP1223914A2 (en) 2002-07-24
ZA200202293B (en) 2003-06-20
DE60013466T2 (de) 2005-01-20
CO5251412A1 (es) 2003-02-28
HK1046641A1 (en) 2003-01-24
JP5561885B2 (ja) 2014-07-30
ES2194618T1 (es) 2003-12-01
PE20010699A1 (es) 2001-07-06
SK6452002A3 (en) 2002-09-10
NZ518165A (en) 2004-03-26
PL200858B1 (pl) 2009-02-27
AR026010A1 (es) 2002-12-26
ATE274899T1 (de) 2004-09-15
WO2001026621A2 (en) 2001-04-19
RU2261098C2 (ru) 2005-09-27
ES2194618T3 (es) 2005-04-01
RU2002112238A (ru) 2004-01-10
TR200200978T2 (tr) 2002-09-23
AU780379B2 (en) 2005-03-17
JP2003511403A (ja) 2003-03-25
DE60013466D1 (de) 2004-10-07
NO20021730D0 (no) 2002-04-12
EP1223914B1 (en) 2004-09-01
BR0014593A (pt) 2002-06-11
CA2386547A1 (en) 2001-04-19
CZ20021315A3 (cs) 2002-07-17
HK1046641B (en) 2005-04-08
CN1173701C (zh) 2004-11-03
KR100708560B1 (ko) 2007-04-19
WO2001026621A3 (en) 2001-10-11
HUP0203148A2 (hu) 2003-01-28
CN1378452A (zh) 2002-11-06
AU1023201A (en) 2001-04-23
IL148777A0 (en) 2002-09-12
IL148777A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
EG22695A (en) Novel phenyl-propargylether derivatives
AU3954702A (en) Substituted imidazopyridines
AU6053701A (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
EG23070A (en) Novel propargylether derivatives
IL155103A0 (en) Substituted c-cyclohexylmethylamine derivatives
PL351241A1 (en) Pharmacological compounds
HUP0203148A3 (en) Orally distintegrating composition comprising mirtazapine
PL356565A1 (pl) Pochodne aminosulfonylobifenylu
IL150557A0 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
GB0302803D0 (en) Not available
IL155106A0 (en) Substituted 1-aminobutan-3-ol derivatives
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
HUP0204217A3 (en) Novel a-500359 derivatives
GB0003022D0 (en) Novel compunds
IL155104A0 (en) 5-amino-1-pentene-3-ol substituted derivatives
HU0002132D0 (en) New arylpiperazinyl-3(2h)-piridazinones
IL151598A0 (en) 2-phenylpyran-4-one derivatives
GB9925274D0 (en) Ruthenium (II) compounds
HU2080U (en) Space-saving vehicle-storing unit
PL335042A1 (en) Shirt
GB0021639D0 (en) Maurotoxin derivatives
GB0016054D0 (en) Ruthenium (II) compounds
SI1246793T1 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives